Skip to main content

Table 4 Details of the blood volume required, assays to be used, intra-assay variability, and measuring range

From: The Brain in Motion II Study: study protocol for a randomized controlled trial of an aerobic exercise intervention for older adults at increased risk of dementia

Markers

Collection tubes

Assay

Sample volume

CV% intra-assay

Measuring range

Hormones

 Estradiol

PST/SST

Electrochemiluminescent immunoassay

500 μL plasma/serum

6

8.4–15,781 pmol/L

 Progesterone

PST/SST

Chemiluminescent immunoassay

200 μL plasma

6

0.48–190.8 nmol/L

 Testosterone

PST/SST

Chemiluminescent immunoassay

0.5 mL plasma/serum

9

0.35–52.1 nmol/L

 Free Testosterone

Calculated

    

 SHBG

SST

Chemiluminescent immunoassay

0.5 mL serum

7

0.02–180 nmol/L

 Albumin

PST/SST

Bromcresol purple binding/colorimetric

0.2 mL plasma/serum

2.5

1–100 g/L

Lipids

 Cholesterol (total)

PST/SST

Enzymatic colorimetric—cholesterol esterase and cholesterol oxidase

0.2 mL plasma/serum

1.7

0.08–20.8 mmol/L

 LDL

Calculated

    

 HDL

PST/SST

Enzymatic colorimetric—PEG-modified cholesterol esterase and cholesterol oxidase

0.2 mL plasma/serum

2.5

0.10–3.12 mmol/L

 TG

PST/SST

Hydrolysis of TG by a lipoprotein lipase to glycerol, followed by oxidation to form hydrogen peroxide

0.2 mL plasma/serum

2.5

0.10–11.40 mmol/L

Thyroid

 TSH

PST/SST

Two-site chemiluminescent immunoassay (Siemens Centaur reagent)

1.0 mL plasma/serum

5.0

0.01–150 mU/L

Kidney

 CBC

EDTA

Beckman-Coulter GEN-S (Calibrated with SCAL kit)

4 mL whole blood

  

 Creatinine

PST/SST

Enzymatic colorimetric—creatininase

0.2 mL plasma/serum

2.0

5–3000 μmol/L

Hepatic

 ALT

PST/SST

Rate UV without pyridoxal phosphate activation

0.2 mL plasma/serum

3.0

4–600 U/L

 Bilirubin (total)

PST/SST

Colorimetric (diazonium ion, with blank)

0.2 mL plasma/serum

3.0

2–600 μmol/L

CVD marker

 hsCRP

PST/SST

Particle enhanced turbidimetric assay

0.2 mL plasma/serum

2.0

0.1–20 mg/L

  1. Notes: All analyses will be carried out at Calgary Laboratory Services. At baseline (0 month), 27–30 mL of blood will be required for measurements of hormones, lipids, and screening markers of thyroid, kidney, hepatic function, and hsCRP (3 × 5 mL gold (SST tubes) + 3 × 4 mL lavender (EDTA tubes)). At the other time points (6 and 18 months), only 18–20 mL of blood will be required for measurements of hormones, lipid profiles, and hsCRP (2 × 5 mL gold (SST tubes) + 2 × 4 mL lavender (EDTA tubes))
  2. Abbreviations: PST, plasma separator tube; SST, serum separator tube; EDTA, ethylenediaminetetra acetic acid in a tripotassium or disodium base; CV%, coefficient of variation; SHBG, sex hormone binding globulin; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TG, triglycerides; TSH, thyroid-stimulating hormone; CBC, complete blood count; ALT, alanine aminotransferase; CVD, cardiovascular disease; hsCRP, high-sensitivity C-reactive protein